Pin Chuan (品川)品川
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司
主要成分Active Ingredients
- 主要成分沙丁胺醇Recorded Chinese composition: 主要成分沙丁胺醇
药物知识说明
主要成分沙丁胺醇是一种在国家药监局注册认定的药品。标注生产企业为天津力生制药股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司、天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司、天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 品川) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 天津力生制药股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司, 天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司, 天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 品川Recorded Chinese name: 品川
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 7.2mg*10片7.2 mg × 10 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 天津力生制药股份有限公司Chinese legal name: 天津力生制药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20050895
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20050895
Manufacturer
Chinese legal name: 天津力生制药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
7.2 mg × 10 tablets
中文说明书原文Original Chinese source label
批准文号
国药准字H20050895
生产企业
天津力生制药股份有限公司(国产)
适应症
本品用于治疗支气管哮喘或喘息型支气管炎等伴有支气管痉挛的呼吸道疾患。
用法用量
口服。不应咀嚼而应用水将整片吞服。一次1片，一日2次。
不良反应
1.较常见的不良反应有:震颤、恶心、心率增快或心搏异常强烈。
2.较少见的不良反应有:头晕、目眩、口咽发干。
禁忌
对本品或其它肾上腺素受体激动剂过敏者禁用。
注意事项
1.高血压、冠状动脉供血不足、糖尿并甲状腺功能亢进等患者应慎用。
2.长期使用可形成耐药性，不仅疗效降低，且有加重哮喘的危险。
贮藏
遮光、密闭、在阴凉干燥处保存。
规格
7.2mg*10片
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.